PACIRA BIOSCIENCES INC (PCRX) Stock Income Statement
NASDAQ:PCRX - Nasdaq - US6951271005 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 869.89M | 700.97M | 674.98M | 666.80M | 541.50M | |||
| Cost Of Goods | 204.73M | 170.43M | 184.67M | 199.30M | 140.30M | |||
| Gross Profit | 665.15M | 530.54M | 490.31M | 467.50M | 401.30M | |||
| Operating Expenses | 559.40M | 432.96M | 402.99M | 396.60M | 268.40M | |||
| Research and Development | 106.92M | 81.58M | 76.26M | 84.80M | 55.50M | |||
| Selling, General, and Administrative Expenses | 380.88M | 294.10M | 269.44M | 254.50M | 199.30M | |||
| Operating Income | 105.75M | 97.57M | 87.32M | 70.90M | 132.80M | |||
| Interest Income/Expense | 5.43M | 3.12M | -8.86M | -35.40M | -30.90M | |||
| Other Income/Expense | 4.03M | -373.00K | -186.00K | -11.30M | -2.70M | |||
| Non Recurring Items | -169.61M | -163.43M | -16.57M | -10.90M | -42.90M | |||
| Income Before Taxes | -54.40M | -63.11M | 61.70M | 13.30M | 56.40M | |||
| Income Tax | 40.35M | 36.45M | 19.75M | -2.60M | 14.40M | |||
| Net Income | -94.75M | -99.56M | 41.95M | 15.90M | 42.00M | |||
| EBITDA | 187.28M | 176.36M | 162.90M | 162.40M | 161.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.06 | -2.15 | 0.80 | 0.34 | 0.92 | |||
| Non GAAP EPS | 3.21 | 3.21 | 2.92 | 2.59 | 2.99 | |||
| Statistics | ||||||||
| Gross Profit Margin | 76.46% | 75.69% | 72.64% | 70.11% | 74.11% | |||
| Profit Margin | -10.89% | -14.20% | 6.22% | 2.38% | 7.76% | |||
| Operating Profit Margin | 12.16% | 13.92% | 12.94% | 10.63% | 24.52% | |||
All data in USD